BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16447133)

  • 21. Tailoring the strategies to specific shortages: pneumococcal conjugate vaccine.
    Peter G
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S138-40. PubMed ID: 16447136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving vaccine supply and development: who needs what?
    Pauly MV
    Health Aff (Millwood); 2005; 24(3):680-9. PubMed ID: 15886159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine shortages eliminate possibility for excess capacity in stockpiles.
    Congeni BL
    Pediatr Ann; 2004 Sep; 33(9):577-83. PubMed ID: 15462572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The National Vaccine Injury Compensation Program.
    Cook KM; Evans G
    Pediatrics; 2011 May; 127 Suppl 1():S74-7. PubMed ID: 21502255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2008 Apr; 121(4):e1016-31. PubMed ID: 18381500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wyeth Pharmaceutical's perspective on vaccine production.
    Stiles GL
    Md Med; 2005; 6(1):22-3. PubMed ID: 15869103
    [No Abstract]   [Full Text] [Related]  

  • 27. The fragility of the U.S. vaccine supply.
    Sloan FA; Berman S; Rosenbaum S; Chalk RA; Giffin RB
    N Engl J Med; 2004 Dec; 351(23):2443-7. PubMed ID: 15575064
    [No Abstract]   [Full Text] [Related]  

  • 28. Vaccine shortages: history, impact, and prospects for the future.
    Hinman AR; Orenstein WA; Santoli JM; Rodewald LE; Cochi SL
    Annu Rev Public Health; 2006; 27():235-59. PubMed ID: 16533116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A qualitative study of physicians' experiences ordering and receiving influenza vaccine during the 2005-2006 influenza season.
    Pyrzanowski JL; Daley MF; Crane LA; Barrow J; Babbel C; Kempe A
    Prev Med; 2008 Aug; 47(2):225-8. PubMed ID: 18599113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccine supply: a cross-national perspective.
    Danzon PM; Pereira NS; Tejwani SS
    Health Aff (Millwood); 2005; 24(3):706-17. PubMed ID: 15886165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza vaccine distribution.
    Goldman GM
    Mo Med; 2001 Feb; 98(2):47-8. PubMed ID: 11242687
    [No Abstract]   [Full Text] [Related]  

  • 32. Influenza vaccine supply, 2005-2006: did we come up short?
    Bardenheier BH; Strikas R; Kempe A; Stokley S; Ellis J
    BMC Health Serv Res; 2007 May; 7():66. PubMed ID: 17480227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global perspectives on vaccine financing.
    Berman S; Giffin RB
    Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine supply, demand, and policy: a primer.
    Muzumdar JM; Cline RR
    J Am Pharm Assoc (2003); 2009; 49(4):e87-99. PubMed ID: 19589753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential population-based electronic data sources for rapid pandemic influenza vaccine adverse event detection: a survey of health plans.
    Moore KM; Duddy A; Braun MM; Platt R; Brown JS
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1137-41. PubMed ID: 18763248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overcoming economic barriers to the optimal use of vaccines.
    Lieu TA; McGuire TG; Hinman AR
    Health Aff (Millwood); 2005; 24(3):666-79. PubMed ID: 15886158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The politics of vaccine production.
    Sauri MA
    Md Med; 2005; 6(1):19-22. PubMed ID: 15869102
    [No Abstract]   [Full Text] [Related]  

  • 40. The fog of research: influenza vaccine trials during the 1918-19 pandemic.
    Eyler JM
    J Hist Med Allied Sci; 2009 Oct; 64(4):401-28. PubMed ID: 19525296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.